DM

Dave Moore

Chief Operating Officer

Toralgen

Indianapolis, Indiana


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Toralgen
Industry
pharmaceuticals
Employees
23.0
Seniority
C suite
Total Funding
2000000.0
Latest Funding
Seed

Technologies

Outlook Microsoft Office 365 Google Cloud Hosting Nginx WordPress.org Mobile Friendly Google Tag Manager Viewpoint Remote AI

Keywords

pharmaceutical manufacturing biopharmaceuticals drug delivery oral therapeutics nanoparticle technology poly-bile nanoparticles oral bioavailability diabetes treatment autoimmune disorders biologics encapsulation injectable alternatives peptide delivery monoclonal antibodies drug formulation pharma collaboration clinical development oral medication targeted drug delivery natural bile acids minimalistic fabrication microfluidics manufacturing semicontinuous processing drug safety bioactivity retention patient compliance therapeutic efficacy production scalability immunomodulators encapsulated small molecules bile-acid polymers homeostasis control metabolic diseases antigen delivery insulin formulations non-injectable drugs nontoxic carriers biopharmaceutical research regulatory approvals therapeutic interventions cmax improvement lake efficacy streamlined manufacturing strategic partnerships funding rounds market potential innovation in medications revolutionary treatments biotechnology startups pharmaceuticals medical

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans